Treatment of Gestational Pemphigoid with Active Disease in the Post-Partum Period

Clinical Scenario

This protocol addresses pemphigoid gestationis presenting with active disease in the post-partum or post-abortion period — in patients who are no longer pregnant. The clinical situation and treatment priorities in this phase differ from those during active pregnancy.

Treatment Approach

First-step management in this setting centres on immunosuppressant or immunomodulating agents, with specific timing considerations for patients who are breastfeeding. Second-line options exist for cases where pharmacoeconomic or other factors guide escalation.

The complete regimen, agent selection, sequencing, and second-line alternatives are available in the full structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.3389/fmed.2020.604945

In the post-partum/post-abortion period, we suggest as first step treatment immunosuppressant/immunomodulating agents, including dapsone and azathioprine, leaving as second choices IVIg and rituximab due to pharmacoeconomic reasons.

View source ↗